Consolidated Condensed Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 29, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net earnings	$ 270.7	$ 333.6
Non-cash items:
Depreciation and amortization expense	93.8	86.8
Stock-based compensation expense	24.1	19.0
Amortization of debt issuance costs	2.9	2.5
Amortization of acquisition-related inventory fair value step-up	1.3	0.0
Loss (gain) on equity investments	1.0	(2.8)
Gain on sale of business	(34.4)	0.0
Gain on sale of property	(2.8)	0.0
Gain on previously held equity interests from combination of business	0.0	(32.7)
Unrealized gain on equity securities measured at fair value	0.0	(17.4)
Impairment charges	0.0	2.1
Change in deferred income taxes	(16.1)	(16.8)
Change in accounts receivable and long-term financing receivables, net	(33.6)	(76.1)
Change in other operating assets and liabilities	(16.8)	(158.4)
Net cash provided by operating activities	290.1	139.8
Cash flows from investing activities:
Proceeds from sale of business, net of cash provided	107.5	0.0
Cash paid for acquisitions, net of cash received	0.0	(277.1)
Payments for additions to property, plant and equipment	(43.5)	(43.0)
Proceeds from sale of property	4.3	0.2
Cash paid for equity investments	(2.7)	(11.3)
Proceeds from sale of equity securities	20.4	5.1
Net cash provided by (used in) investing activities	86.0	(326.1)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	0.0	235.0
Repayment of long-term debt	(240.0)	(185.0)
Net proceeds from short-term borrowings	1.4	3.6
Payments of common stock cash dividend	(11.7)	(12.0)
Purchases of treasury stock	(61.6)	(288.0)
Proceeds from stock option exercises	6.0	1.3
Other financing activities	(7.4)	(3.8)
Net cash used in financing activities	(313.3)	(248.9)
Effect of exchange rate changes on cash and cash equivalents	(3.7)	(15.7)
Net change in cash and cash equivalents	59.1	(450.9)
Beginning balance of cash and cash equivalents	204.5	572.6
Ending balance of cash and cash equivalents	$ 263.6	$ 121.7